Citations (111)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Fan Cheng & Fayyaz Ahmed. (2021) OnabotulinumtoxinA for the prophylactic treatment of headaches in adult patients with chronic migraine: a safety evaluation. Expert Opinion on Drug Safety 20:11, pages 1275-1289.
Read now
Read now
Salih Eren Meral, Hakan Hıfzı Tüz & Özgür Başlarlı. (2021) Evaluation of patient satisfaction after botulinum toxin A injection for the management of masticatory myofascial pain and dysfunction – A pilot study. CRANIO® 39:1, pages 12-16.
Read now
Read now
Souphiyeh Samizadeh & Koenraad De Boulle. (2018) Botulinum neurotoxin formulations: overcoming the confusion. Clinical, Cosmetic and Investigational Dermatology 11, pages 273-287.
Read now
Read now
Susan A. Shorter, Alexander S. Gollings, Monique A. M. Gorringe-Pattrick, J. Emma Coakley, Paul D. R. Dyer & Simon C. W. Richardson. (2017) The potential of toxin-based drug delivery systems for enhanced nucleic acid therapeutic delivery. Expert Opinion on Drug Delivery 14:5, pages 685-696.
Read now
Read now
Roshan Kukreja & Bal Ram Singh. (2015) The botulinum toxin as a therapeutic agent: molecular and pharmacological insights. Research and Reports in Biochemistry 5, pages 173-183.
Read now
Read now
Tatjana Pavicic, Welf Prager, Markus Klöppel, Simon Ravichandran & Olivier Galatoire. (2015) IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study. Clinical, Cosmetic and Investigational Dermatology 8, pages 135-142.
Read now
Read now
Neslihan Tinastepe, Burcu Bal Küçük & Koray Oral. (2015) Botulinum toxin for the treatment of bruxism. CRANIO® 33:4, pages 292-299.
Read now
Read now
K. Everaert, A. S. Goessaert & J. Vande Walle. (2014) Arterial hypertension related to the injection of onabotulinumtoxinA in the detrusor. Acta Clinica Belgica 69:2, pages 122-124.
Read now
Read now
Welf Prager. (2013) Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines. Clinical Pharmacology: Advances and Applications 5, pages 39-52.
Read now
Read now
Carrie E Robertson & Ivan Garza. (2012) Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine. Neuropsychiatric Disease and Treatment 8, pages 35-48.
Read now
Read now
Joohi Jimenez-Shahed. (2012) A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins. Neuropsychiatric Disease and Treatment 8, pages 13-25.
Read now
Read now
An-Sofie OM Goessaert & Karel CMM Everaert. (2012) Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis. Expert Review of Neurotherapeutics 12:7, pages 763-775.
Read now
Read now
Juwan Park, Michael S Lee & Andrew R Harrison. (2011) Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm. Clinical Ophthalmology 5, pages 725-732.
Read now
Read now
Yu-Jin Oh, Na-Young Lee, Dong-Hye Suh, Jea-Sook Koh, Sang-Jun Lee & Min-Kyung Shin. (2011) A split-face study using Botulinum Toxin type B to decrease facial Erythema index. Journal of Cosmetic and Laser Therapy 13:5, pages 243-248.
Read now
Read now
Lisa Shaw & Helen Rodgers. (2009) Botulinum toxin type A for upper limb spasticity after stroke. Expert Review of Neurotherapeutics 9:12, pages 1713-1725.
Read now
Read now
D. M. Cullen, J. J. W. Boyle, P. L. Silbert, B. J. Singer & K. P. Singer. (2007) Botulinum toxin injection to facilitate rehabilitation of muscle imbalance syndromes in sports medicine. Disability and Rehabilitation 29:23, pages 1832-1839.
Read now
Read now
Jean-Michel Gracies, Barbara J. Singer & John W. Dunne. (2007) The role of botulinum toxin injections in the management of muscle overactivity of the lower limb. Disability and Rehabilitation 29:23, pages 1789-1805.
Read now
Read now
Articles from other publishers (94)
Hatice Hosgor, Fatih Mehmet Coskunses & Sezen Altindis. (2023) Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison. Journal of Stomatology, Oral and Maxillofacial Surgery 124:4, pages 101434.
Crossref
Crossref
Parisa Gazerani. (2022) How Does Botulinum Toxin Inhibit Itch?. Toxins 14:10, pages 701.
Crossref
Crossref
Dong Geon Lee, Jung Eun Kim, Woo Shun Lee, Moon-Bum Kim, Chang-hun Huh, Yang Won Lee, Gwang Seong Choi, Jee-Bum Lee, Dong Soo Yu, Min Kyung Shin, Mi Ryung Roh, Hyo Hyun Ahn, Won-serk Kim, Jong Hee Lee, Kui Young Park, Jin Park, Weon Ju Lee, Mi Youn Park & Hoon Kang. (2022) A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Neu-BoNT/A in Treatment of Primary Axillary Hyperhidrosis. Aesthetic Plastic Surgery 46:3, pages 1400-1406.
Crossref
Crossref
Margit L.W. Juhasz, Scott R. Freeman & Joel L. Cohen. 2022. Cosmetic Dermatology. Cosmetic Dermatology
451
465
.
Bruna Luiza Ribeiro de Almeida, Alex Giacomini & Juliana Geremias Chichorro. (2022) BOTULINUM. Health and Society 2:01.
Crossref
Crossref
Napamon Supornpun, Paisal Rummaneethorn, Thamthiwat Nararatwanchai, Tawee Saiwichai & Sirinthip Chaichalotornkul. (2022) Incobotulinum toxin A with a one-year long-lasting effect for trapezius contouring and superior efficacy for the treatment of trapezius myalgia. Journal of Cutaneous and Aesthetic Surgery 15:2, pages 168.
Crossref
Crossref
亚辉 秦. (2022) Advances in Application of Botulinum Toxin Type A in Neurology. Advances in Clinical Medicine 12:03, pages 1679-1685.
Crossref
Crossref
Po-Cheng Hsu, Ke-Vin Chang, Yi-Hsiang Chiu, Wei-Ting Wu & Levent Özçakar. (2022) Comparative Effectiveness of Botulinum Toxin Injections and Extracorporeal Shockwave Therapy for Post-Stroke Spasticity: A Systematic Review and Network Meta-Analysis. eClinicalMedicine 43, pages 101222.
Crossref
Crossref
Raja Mehanna & Joseph Jankovic. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1095
1143
.
Thays Crosara Abrahão Cunha, Ana Claudia Gontijo Couto, Eduardo Januzzi, Rafael Tardin Rosa Ferraz Gonçalves, Graziella Silva & Cassia Regina Silva. (2021) Analgesic potential of different available commercial brands of botulinum neurotoxin-A in formalin-induced orofacial pain in mice. Toxicon: X 12, pages 100083.
Crossref
Crossref
Warner W. Carr, Neal Jain & J. Wesley Sublett. (2021) Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications. Advances in Therapy 38:10, pages 5046-5064.
Crossref
Crossref
Z. A. Zalyalova & E. R. Iusupova. (2021) Rehabilitation approaches in cervical dystonia. Neurology, Neuropsychiatry, Psychosomatics 13:4, pages 103-108.
Crossref
Crossref
Gerard E. Francisco & Sheng Li. 2021. Braddom's Physical Medicine and Rehabilitation. Braddom's Physical Medicine and Rehabilitation
447
468.e6
.
J. Heckelmann, D. Tapias & M. Dafotakis. (2020) Botulinumtoxin in der NeurologieBotulinum toxin in neurology. DGNeurologie 4:1, pages 12-15.
Crossref
Crossref
Raja Mehanna & Joseph Jankovic. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1
48
.
Maren Schenke, Brit-Maren Schjeide, Gerhard P. Püschel & Bettina Seeger. (2020) Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays. Toxins 12:5, pages 276.
Crossref
Crossref
Bernard Poulain, Emmanuel Lemichez & Michel R. Popoff. (2020) Neuronal selectivity of botulinum neurotoxins. Toxicon 178, pages 20-32.
Crossref
Crossref
Shiri Nawrocki & Jisun Cha. (2020) Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis. Journal of the American Academy of Dermatology 82:4, pages 969-979.
Crossref
Crossref
Wooyoung Jang & Jinyoung Youn. 2020. Hemifacial Spasm. Hemifacial Spasm
127
134
.
Khashayar Dashtipour & Paul Spanel. 2020. Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine. Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine
27
41
.
Svetlana Goločorbin-Kon, Aleksandra Mikov, Velibor Vasović, Nebojša Pavlović, Mladena Lalić-Popović, Lucija Vasović, Saša Vukmirović, Sanja Kecman & Momir Mikov. (2019) Botulinum toxin: Poison and medicine. PONS - medicinski casopis 16:1, pages 24-31.
Crossref
Crossref
Sheng Li & Gerard E. Francisco. 2019. Stroke Rehabilitation. Stroke Rehabilitation
133
153
.
Michael F. Vaezi & Brian M. Lappas. 2019. The SAGES Manual of Foregut Surgery. The SAGES Manual of Foregut Surgery
409
421
.
Dirk Dressler. 2021. Botulinum Toxin Therapy. Botulinum Toxin Therapy
93
106
.
Tomoko Kohda, Yasushi Torii & Hidemitsu Nakajima. 2018. Botulinum Toxin. Botulinum Toxin.
Alessio Baricich, Alessandro Picelli, Andrea Santamato, Stefano Carda, Alessandro de Sire, Nicola Smania, Carlo Cisari & Marco Invernizzi. (2018) Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment. Clinical Drug Investigation 38:11, pages 991-1000.
Crossref
Crossref
Yasushi Torii, Mikio Sasaki, Min-Chul Shin, Norio Akaike & Ryuji Kaji. (2018) Comparison of efficacy and toxicity between botulinum toxin subtypes A1 and A2 in cynomolgus macaques. Toxicon 153, pages 114-119.
Crossref
Crossref
Dirk Dressler, Lizhen Pan & Fereshte Adib Saberi. (2018) Antibody-induced failure of botulinum toxin therapy: re-start with low-antigenicity drugs offers a new treatment opportunity. Journal of Neural Transmission 125:10, pages 1481-1486.
Crossref
Crossref
Thomas M. Feltrup, Kruti Patel, Raj Kumar, Shuowei Cai & Bal Ram Singh. (2018) A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin. Scientific Reports 8:1.
Crossref
Crossref
L. Huang. (2018) Beneficial effect of botulinum toxin A on secondary ischaemic injury of skin flaps in rats. British Journal of Oral and Maxillofacial Surgery 56:2, pages 144-147.
Crossref
Crossref
Naomi Prado, Louisa Rose & Peter Korczak. (2018) Botox: It's Not Just About The Wrinkles. Dental Update 45:1, pages 32-37.
Crossref
Crossref
Gerard E. Francisco. 2018. Braddom's Rehabilitation Care: A Clinical Handbook. Braddom's Rehabilitation Care: A Clinical Handbook
157
163.e13
.
Melinda Aquino, Heesung Kang & Karina Gritsenko. 2018. Essentials of Interventional Techniques in Managing Chronic Pain. Essentials of Interventional Techniques in Managing Chronic Pain
629
633
.
Ki Su Kim, Yun Seop Kim, Kai Bao, Hideyuki Wada, Hak Soo Choi & Sei Kwang Hahn. (2017) Bioimaging of botulinum toxin and hyaluronate hydrogels using zwitterionic near-infrared fluorophores. Biomaterials Research 21:1.
Crossref
Crossref
R. Laskawi & A. Olthoff. (2017) Botulinumtoxin in der HNO‑Heilkunde – ein UpdateBotulinum toxin in otorhinolaryngology – an update. HNO 65:10, pages 859-870.
Crossref
Crossref
Cerrene N. Giordano, Seth L. Matarasso & David M. Ozog. (2017) Injectable and topical neurotoxins in dermatology. Journal of the American Academy of Dermatology 76:6, pages 1027-1042.
Crossref
Crossref
Azza S. Shehata, Nabila M. Al-Ghonemy, Samah M. Ahmed & Samar R. Mohamed. (2017) Effect of mesenchymal stem cells on induced skeletal muscle chemodenervation atrophy in adult male albino rats. The International Journal of Biochemistry & Cell Biology 85, pages 135-148.
Crossref
Crossref
Dirk Dressler & Fereshte Adib Saberi. (2016) Safety of botulinum toxin short interval therapy using incobotulinumtoxin A. Journal of Neural Transmission 124:4, pages 437-440.
Crossref
Crossref
Melissa R. Kaufman. 2017. Complications of Female Incontinence and Pelvic Reconstructive Surgery. Complications of Female Incontinence and Pelvic Reconstructive Surgery
317
325
.
Vladimír Šámal & Jan Mečl. (2016) Use of botulinum toxin in the treatment of urinary incontinence. Urologie pro praxi 17:4, pages 172-176.
Crossref
Crossref
Johnny P. Mai, Catherine T. Haring, Steven Hopping & Houtan Chaboki. (2016) “Nonsurgical Rhinoplasty”. The American Journal of Cosmetic Surgery 33:3, pages 133-139.
Crossref
Crossref
Michael S. Gart & Karol A. Gutowski. (2016) Overview of Botulinum Toxins for Aesthetic Uses. Clinics in Plastic Surgery 43:3, pages 459-471.
Crossref
Crossref
Francesco Scaglione. (2016) Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice. Toxins 8:3, pages 65.
Crossref
Crossref
Hiroshi Mashimo. 2016. Achalasia. Achalasia
31
38
.
Michael S. Gart & Karol A. Gutowski. (2015) Aesthetic Uses of Neuromodulators. Plastic and Reconstructive Surgery 136, pages 62S-71S.
Crossref
Crossref
J. Daniel Jensen, Scott R. Freeman & Joel L. Cohen. 2015. Cosmetic Dermatology. Cosmetic Dermatology
364
374
.
Neslihan Tinastepe, Burcu Bal Küçük & Koray Oral. (2015) Botulinum toxin for the treatment of bruxism. CRANIO® 33:4, pages 292-299.
Crossref
Crossref
Fraser E. Houston, Brian A. Hain, Thomas J. Adams, Kati L. Houston, Roderic O'Keeffe & Stephen L. Dodd. (2015) Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle. Journal of Applied Physiology 119:1, pages 83-92.
Crossref
Crossref
Yasushi Torii, Yoshitaka Goto, Shinji Nakahira, Shunji Kozaki, Ryuji Kaji & Akihiro Ginnaga. (2014) Comparison of Systemic Toxicity between Botulinum Toxin Subtypes A1 and A2 in Mice and Rats. Basic & Clinical Pharmacology & Toxicology 116:6, pages 524-528.
Crossref
Crossref
Benjamin P. Erickson, Wendy W. Lee, Joel Cohen & Lisa D. Grunebaum. (2015) The Role of Neurotoxins in the Periorbital and Midfacial Areas. Facial Plastic Surgery Clinics of North America 23:2, pages 243-255.
Crossref
Crossref
Bernard Poulain, Jordi Molgó & Michel R. Popoff. 2015. The Comprehensive Sourcebook of Bacterial Protein Toxins. The Comprehensive Sourcebook of Bacterial Protein Toxins
287
336
.
M. Karlqvist, K. Rosell, A. Rystedt, K. Hymnelius & C. Swartling. (2014) Botulinum toxin B in the treatment of craniofacial hyperhidrosis. Journal of the European Academy of Dermatology and Venereology 28:10, pages 1313-1317.
Crossref
Crossref
Yasushi Torii, Yoshitaka Goto, Shinji Nakahira, Shunji Kozaki & Akihiro Ginnaga. (2014) Comparison of the immunogenicity of botulinum toxin type A and the efficacy of A1 and A2 neurotoxins in animals with A1 toxin antibodies. Toxicon 77, pages 114-120.
Crossref
Crossref
Andy Pickett. 2014. Clinical Applications of Botulinum Neurotoxin. Clinical Applications of Botulinum Neurotoxin
7
49
.
Raja Mehanna & Joseph Jankovic. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
553
590
.
A R ARTEMENKO, A V SAIBEL, S S NIKITIN & A L KURENKOV. (2013) A comparative, prospective, split-face, blind study of the efficacy of two botulinum toxin type A drugs (Disport® and Xeomin®) used to correct lateral periorbital wrinkles. Vestnik dermatologii i venerologii 89:6, pages 140-149.
Crossref
Crossref
Tanya K. Meyer, Amanda HuAllen D. Hillel. (2013) Voice disorders in the workplace: Productivity in spasmodic dysphonia and the impact of botulinum toxin. The Laryngoscope 123:S6.
Crossref
Crossref
Dennis F. Schweizer, Riccardo Schweizer, Shengye Zhang, Pranitha Kamat, Claudio Contaldo, Robert Rieben, Daniel Eberli, Pietro Giovanoli, Dominique Erni & Jan A. Plock. (2013) Botulinum toxin A and B raise blood flow and increase survival of critically ischemic skin flaps. Journal of Surgical Research 184:2, pages 1205-1213.
Crossref
Crossref
Roberta Ravenni, Domenico De Grandis & Alberto Mazza. (2013) Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence. Neurological Sciences 34:7, pages 1043-1048.
Crossref
Crossref
Dominique El-Khawand, Salim Wehbe & Kristene Whitmore. (2013) Botulinum toxin for conditions of the female pelvis. International Urogynecology Journal 24:7, pages 1073-1081.
Crossref
Crossref
Alberto Esquenazi, Alberto Albanese, Michael B. Chancellor, Elie Elovic, Karen R. Segal, David M. Simpson, Christopher P. Smith & Anthony B. Ward. (2013) Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon 67, pages 115-128.
Crossref
Crossref
Ann P. Tighe & Giampietro Schiavo. (2013) Botulinum neurotoxins: Mechanism of action. Toxicon 67, pages 87-93.
Crossref
Crossref
Jack J. ChenKhashayar Dashtipour. (2013) Abo‐, Inco‐, Ona‐, and Rima‐Botulinum Toxins in Clinical Therapy: A Primer. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33:3, pages 304-318.
Crossref
Crossref
Rishi Vashishta, Shaun A. Nguyen, David R. White & M. Boyd Gillespie. (2012) Botulinum Toxin for the Treatment of Sialorrhea. Otolaryngology–Head and Neck Surgery 148:2, pages 191-196.
Crossref
Crossref
Norio Akaike, Min‐Chul Shin, Masahito Wakita, Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga, Keiko Kato, Ryuji Kaji & Shunji Kozaki. (2012) Transsynaptic inhibition of spinal transmission by A2 botulinum toxin. The Journal of Physiology 591:4, pages 1031-1043.
Crossref
Crossref
M. Brown, G. Nicholson, M. C. Ardila, A. Satorius, R. S. Broide, K. Clarke, T. Hunt & J. Francis. (2012) Comparative evaluation of the potency and antigenicity of two distinct BoNT/A-derived formulations. Journal of Neural Transmission 120:2, pages 291-298.
Crossref
Crossref
Michel R. Popoff, Christelle Mazuet & B. Poulain. 2013. The Prokaryotes. The Prokaryotes
247
290
.
Mary Ann Thenganatt & Stanley Fahn. (2012) Botulinum Toxin for the Treatment of Movement Disorders. Current Neurology and Neuroscience Reports 12:4, pages 399-409.
Crossref
Crossref
Fernando L. Pagan & Andrew Harrison. (2012) A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin®: A new botulinum neurotoxin A. Parkinsonism & Related Disorders 18:5, pages 441-445.
Crossref
Crossref
Joohi Jimenez-Shahed & Joseph Jankovic. 2012. Handbook of Dystonia. Handbook of Dystonia
1
10
.
Daniel Truong. (2012) Botulinum toxins in the treatment of primary focal dystonias. Journal of the Neurological Sciences 316:1-2, pages 9-14.
Crossref
Crossref
Malene Rohrsted, Cecilie Nordsten & Per Bagi. (2012) Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity. Nephro-Urology Monthly 4:2, pages 437-442.
Crossref
Crossref
Timothy Corcoran Flynn. (2012) Advances in the use of botulinum neurotoxins in facial esthetics. Journal of Cosmetic Dermatology 11:1, pages 42-50.
Crossref
Crossref
Martina Kerscher, Susanna Roll, Andreas Becker & Walter Wigger-Alberti. (2011) Comparison of the spread of three botulinum toxin type A preparations. Archives of Dermatological Research 304:2, pages 155-161.
Crossref
Crossref
Dermot Thomas McDowell, Damien Noone, Farhan Tareen, Mary Waldron & Feargal Quinn. (2012) Urinary incontinence in children: botulinum toxin is a safe and effective treatment option. Pediatric Surgery International 28:3, pages 315-320.
Crossref
Crossref
Sabine Pellett. 2013. Botulinum Neurotoxins. Botulinum Neurotoxins
257
285
.
Sabine Pellett. 2013. Botulinum Neurotoxins. Botulinum Neurotoxins
257
285
.
Juwan Park, Andrew R. Harrison & Michael S. Lee. 2013. Craniofacial Muscles. Craniofacial Muscles
287
321
.
B.G. Lapatki, J.P. van Dijk, B.P.C. van de Warrenburg & M.J. Zwarts. (2011) Botulinum toxin has an increased effect when targeted toward the muscle’s endplate zone: A high-density surface EMG guided study. Clinical Neurophysiology 122:8, pages 1611-1616.
Crossref
Crossref
Carl H. Manstein & Omar E. Beidas. (2011) Comparing Clinical Efficacy of Botox and Dysport in a Small Group of Patients. Plastic and Reconstructive Surgery 128:1, pages 26e-27e.
Crossref
Crossref
DINAH REDDIHOUGH & H KERR GRAHAM. (2011) Botulinum toxin type B for sialorrhea in children with cerebral palsy. Developmental Medicine & Child Neurology 53:6, pages 488-489.
Crossref
Crossref
W. Prager, E. Wißmüller, B. Kollhorst, A. Böer & I. Zschocke. (2011) Botulinumtoxin Typ A im HalbseitenvergleichTreatment of crow’s feet with two different botulinum toxin type. Der Hautarzt 62:5, pages 375-379.
Crossref
Crossref
Yasushi Torii, Norio Akaike, Tetsuhiro Harakawa, Keiko Kato, Nakaba Sugimoto, Yoshitaka Goto, Shinji Nakahira, Tomoko Kohda, Shunji Kozaki, Ryuji Kaji & Akihiro Ginnaga. (2011) Type A1 but Not Type A2 Botulinum Toxin Decreases the Grip Strength of the Contralateral Foreleg Through Axonal Transport From the Toxin-Treated Foreleg of Rats. Journal of Pharmacological Sciences 117:4, pages 275-285.
Crossref
Crossref
G. Kranz, A. Paul, B. Voller, M. Posch, C. Windischberger, E. Auff & T. Sycha. (2011) Long-term efficacy and respective potencies of botulinum toxin A and B: a randomized, double-blind study. British Journal of Dermatology 164:1, pages 176-181.
Crossref
Crossref
Yasushi Torii, Naotoshi Kiyota, Nakaba Sugimoto, Yuichiro Mori, Yoshitaka Goto, Tetsuhiro Harakawa, Shinji Nakahira, Ryuji Kaji, Shunji Kozaki & Akihiro Ginnaga. (2011) Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test. Toxicon 57:1, pages 93-99.
Crossref
Crossref
Francis O. Walker. 2011. Neuromuscular Ultrasound. Neuromuscular Ultrasound
150
165
.
A. Esquenazi, I. Novak, G. Sheean, B. J. Singer & A. B. Ward. (2010) International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments – introduction. European Journal of Neurology 17:s2, pages 1-8.
Crossref
Crossref
D. Dressler. (2010) Botulinum toxin for treatment of dystonia. European Journal of Neurology 17:s1, pages 88-96.
Crossref
Crossref
B. Poulain. (2010) La neurotoxine botulinique. Revue Neurologique 166:1, pages 7-20.
Crossref
Crossref
José Francisco & Isabel Pareés Moreno. 2010. Toxina Botulínica. Toxina Botulínica
3
15
.
Peter B. Arnold, Chris A. Campbell, George Rodeheaver, Wyndell Merritt, Raymond F. Morgan & David B. Drake. (2009) Modification of Blood Vessel Diameter following Perivascular Application of Botulinum Toxin-A. HAND 4:3, pages 302-307.
Crossref
Crossref
Parisa Gazerani. 2009. Peripheral Receptor Targets for Analgesia. Peripheral Receptor Targets for Analgesia
297
324
.
Cidronio Albavera-Hernández, Jorge M Rodríguez & Alvaro J Idrovo. (2009) Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Clinical Rehabilitation 23:5, pages 394-407.
Crossref
Crossref
A. Chow & E.P. Wilder-Smith. (2009) Effect of transdermal botulinum toxin on sweat secretion in subjects with idiopathic palmar hyperhidrosis. British Journal of Dermatology 160:3, pages 721-722.
Crossref
Crossref